Highlights from the journal CHEST®, December 2022

Glenview, Illinois – Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The December issue of the CHEST journal contains 36 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“Well-suited for the final issue of 2022, the December issue of the journal CHEST includes articles that look back at lessons learned from the COVID-19 pandemic and insights into planning for future surges,” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “’COVID-19: Lessons Learned, Lessons Unlearned, Lessons for the Future’ was written by editorial board members for the critical care section of the journal CHEST and ‘A Regional Command Center for Pandemic Surge’ is a prospective observational study conducted in Catalonia from March 15, 2020, to July 1, 2021.”

Also included in the current issue of the journal CHEST:

• Chest Infections
  Recommending constant microbiological surveillance, “Multidrug-Resistant and Extended-Spectrum β-Lactamase Gram-Negative Bacteria in Bilateral Lung Transplant Recipients” discourages the use of empirical broad-spectrum antibiotics.
• Critical Care
  A large, multicenter retrospective study, “Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure” finds large variation in the use of inhaled nitric oxide and inhaled epoprostenol during acute respiratory failure across the United States. A visual abstract for the research can be viewed here.
• Diffuse Lung Disease
  Looking at patients with lymphangioleiomyomatosis, “Impact of Age, Menopause, and Sirolimus on Spontaneous Pneumothoracesin Lymphangioleiomyomatosis” research finds increasing age and menopausal status are associated with a reduced risk of development of spontaneous pneumothoraces (SP), and the use of mechanistic target of rapamycin inhibitors is associated with reduced recurrence risk of SP. A visual abstract for the research can be viewed here.
• Thoracic Oncology
  The largest study to date on the topic, “Bleeding Risk With Combination Intrapleural Fibrinolytic and EnzymeTherapy in Pleural Infection,” shows that, aside from specific scenarios, safety or risk of bleeding alone should no longer be a deterrent to the use of intrapleural fibrinolytic and enzyme therapy in pleural infection. A visual abstract for the research can be viewed here.

To view the entire December issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.